Michigan Medicine: Oral Nanomedicine Boosts Effectiveness of Cancer Immunotherapies
August 26, 2026
August 26, 2026
ANN ARBOR, Michigan, Aug. 26 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
New oral nanomedicine boosts effectiveness of cancer immunotherapies
Microbial metabolite 3,4-dihydroxybenzoic acid, derived from dietary fiber, improves acid influences anti-tumor immunity in mice
-
Immune checkpoint blockade is a form of cancer treatment that works by rele . . .
* * *
New oral nanomedicine boosts effectiveness of cancer immunotherapies
Microbial metabolite 3,4-dihydroxybenzoic acid, derived from dietary fiber, improves acid influences anti-tumor immunity in mice
-
Immune checkpoint blockade is a form of cancer treatment that works by rele . . .
